HUE047062T2 - Angiotenzin II alacsony vérnyomás kombinációs kezelésére - Google Patents

Angiotenzin II alacsony vérnyomás kombinációs kezelésére

Info

Publication number
HUE047062T2
HUE047062T2 HUE14872684A HUE14872684A HUE047062T2 HU E047062 T2 HUE047062 T2 HU E047062T2 HU E14872684 A HUE14872684 A HU E14872684A HU E14872684 A HUE14872684 A HU E14872684A HU E047062 T2 HUE047062 T2 HU E047062T2
Authority
HU
Hungary
Prior art keywords
angiotensin
hypertension
combination treatment
treatment
combination
Prior art date
Application number
HUE14872684A
Other languages
English (en)
Hungarian (hu)
Inventor
Lakhmir Chawla
Original Assignee
The George Washington Univ A Congressionally Chartered Not For Profit Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53367119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE047062(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The George Washington Univ A Congressionally Chartered Not For Profit Corporation filed Critical The George Washington Univ A Congressionally Chartered Not For Profit Corporation
Publication of HUE047062T2 publication Critical patent/HUE047062T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE14872684A 2013-12-18 2014-12-18 Angiotenzin II alacsony vérnyomás kombinációs kezelésére HUE047062T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US201461955706P 2014-03-19 2014-03-19

Publications (1)

Publication Number Publication Date
HUE047062T2 true HUE047062T2 (hu) 2020-04-28

Family

ID=53367119

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14872684A HUE047062T2 (hu) 2013-12-18 2014-12-18 Angiotenzin II alacsony vérnyomás kombinációs kezelésére

Country Status (25)

Country Link
US (7) US9220745B2 (enExample)
EP (2) EP2986308B1 (enExample)
JP (4) JP6824739B2 (enExample)
KR (4) KR20220028125A (enExample)
CN (4) CN106061493A (enExample)
AU (3) AU2014364528C1 (enExample)
BR (1) BR112016013961A2 (enExample)
CA (1) CA2933601A1 (enExample)
CY (1) CY1122604T1 (enExample)
DK (2) DK2986308T3 (enExample)
EA (1) EA037823B1 (enExample)
ES (2) ES2771749T3 (enExample)
FI (1) FI3607962T3 (enExample)
HR (2) HRP20200009T1 (enExample)
HU (1) HUE047062T2 (enExample)
IL (1) IL246162B (enExample)
LT (2) LT2986308T (enExample)
MX (2) MX380968B (enExample)
NZ (1) NZ721089A (enExample)
PL (2) PL3607962T3 (enExample)
PT (2) PT3607962T (enExample)
RS (2) RS59804B1 (enExample)
SI (2) SI3607962T1 (enExample)
SM (2) SMT202500427T1 (enExample)
WO (1) WO2015095535A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
MX2017000306A (es) * 2014-07-08 2017-07-10 La Jolla Pharma Co Metodos para tratar hipotension.
WO2016153558A1 (en) 2015-03-20 2016-09-29 Atkinson Arthur J Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
AU2017205168A1 (en) * 2016-01-07 2018-08-16 La Jolla Pharma, Llc Methods for administering angiotensin II
KR20180108630A (ko) * 2016-01-07 2018-10-04 라 졸라 파마슈티칼 컴파니 혈관수축제의 투여 방법
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) * 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法
US20250366467A1 (en) * 2022-06-15 2025-12-04 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
WO2024129057A1 (en) * 2022-12-12 2024-06-20 Proletariat Therapeutics, Inc. Methods of treating cardiac injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
CA2448051A1 (en) 2001-06-04 2002-12-12 Human Genome Sciences, Inc. Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
ATE507243T1 (de) 2005-09-29 2011-05-15 Fibrogen Inc Verfahren zur senkung des blutdrucks
CN101351215A (zh) * 2005-12-30 2009-01-21 霍华德·弗洛里实验生理学及医学研究所 治疗方法
CA2655144A1 (en) 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
WO2008059062A1 (en) 2006-11-17 2008-05-22 Da Volterra Colonic delivery using zn/pectin beads with a eudragit coating.
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
MX2011005672A (es) 2008-11-28 2011-06-20 Abbott Lab Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
KR20130026504A (ko) 2010-07-14 2013-03-13 큠버랜드 에멀징 테크놀로지스 아이앤씨 트롬복산-a2 수용체 길항제를 이용한 간신증후군 및 간성뇌증의 치료방법
CN105592855A (zh) 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
MX2017000306A (es) 2014-07-08 2017-07-10 La Jolla Pharma Co Metodos para tratar hipotension.
KR20180108630A (ko) 2016-01-07 2018-10-04 라 졸라 파마슈티칼 컴파니 혈관수축제의 투여 방법
AU2017205168A1 (en) 2016-01-07 2018-08-16 La Jolla Pharma, Llc Methods for administering angiotensin II
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法

Also Published As

Publication number Publication date
JP2025114753A (ja) 2025-08-05
EP2986308A1 (en) 2016-02-24
AU2014364528A1 (en) 2016-06-30
PL3607962T3 (pl) 2026-03-09
ES3055611T3 (en) 2026-02-13
EP3607962B1 (en) 2025-08-13
LT2986308T (lt) 2020-03-25
CN119700926A (zh) 2025-03-28
MX2020011190A (es) 2020-11-13
KR20240154702A (ko) 2024-10-25
EP3607962A1 (en) 2020-02-12
IL246162B (en) 2020-03-31
US10765722B2 (en) 2020-09-08
US20190328827A1 (en) 2019-10-31
ES2771749T3 (es) 2020-07-07
US20190070250A1 (en) 2019-03-07
KR20220028125A (ko) 2022-03-08
US11096983B2 (en) 2021-08-24
US20230226141A1 (en) 2023-07-20
JP6824739B2 (ja) 2021-02-03
AU2024219851A1 (en) 2024-10-10
US10493124B2 (en) 2019-12-03
KR20230051721A (ko) 2023-04-18
JP2022137224A (ja) 2022-09-21
AU2014364528A9 (en) 2016-07-28
HRP20251406T1 (hr) 2026-02-27
PL2986308T3 (pl) 2020-05-18
FI3607962T3 (fi) 2025-11-24
LT3607962T (lt) 2026-01-12
JP7175506B2 (ja) 2022-11-21
EP2986308B1 (en) 2019-10-16
CN112546197A (zh) 2021-03-26
CA2933601A1 (en) 2015-06-25
EA037823B1 (ru) 2021-05-25
BR112016013961A2 (pt) 2017-10-10
MX2016008108A (es) 2017-03-09
MX380968B (es) 2025-03-12
SMT202500427T1 (it) 2026-01-12
AU2014364528C1 (en) 2021-01-07
JP2017501154A (ja) 2017-01-12
DK3607962T3 (da) 2025-11-17
JP2019214610A (ja) 2019-12-19
WO2015095535A1 (en) 2015-06-25
PT3607962T (pt) 2025-11-18
EA201691258A1 (ru) 2016-11-30
US11559559B2 (en) 2023-01-24
CY1122604T1 (el) 2021-03-12
CN111920939A (zh) 2020-11-13
EP2986308A4 (en) 2017-01-11
DK2986308T3 (en) 2020-01-27
US20150164980A1 (en) 2015-06-18
US20180193407A1 (en) 2018-07-12
RS59804B1 (sr) 2020-02-28
CN106061493A (zh) 2016-10-26
US10028995B2 (en) 2018-07-24
US20160129072A1 (en) 2016-05-12
US9220745B2 (en) 2015-12-29
SMT202000018T1 (it) 2020-03-13
RS67626B1 (sr) 2026-02-27
NZ721089A (en) 2022-10-28
KR20160117437A (ko) 2016-10-10
SI2986308T1 (sl) 2020-03-31
HRP20200009T1 (hr) 2020-03-20
US20220047669A1 (en) 2022-02-17
PT2986308T (pt) 2020-01-21
SI3607962T1 (sl) 2026-02-27
KR102399383B1 (ko) 2022-05-19
AU2014364528B2 (en) 2020-08-27
WO2015095535A9 (en) 2016-07-14
AU2020277230A1 (en) 2020-12-24
IL246162A0 (en) 2016-07-31

Similar Documents

Publication Publication Date Title
IL280908B (en) Combination therapy with neoantigen vaccine
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
AR095266A1 (es) Inhibidores de bromodominios tetraciclicos
EP2989885A4 (en) HARVESTER
PL3030519T3 (pl) Trójpierścieniowe związki benzoksaborolu i ich zastosowania
LT2986308T (lt) Angiotenzino ii derinys hipotenzijai gydyti
EP2982331A4 (en) Treatment tool
HRP20182072T1 (hr) Rastavljiva samosklopiva struktura
LT3563837T (lt) Terapija bakteriofagu
DK3044229T3 (da) Peptider til anvendelse i behandlingen af oral mucositis
DK3071192T3 (da) Curcuphenolforbindelse til anvendelse i behandling af cancer
HRP20181307T1 (hr) Postupak izrade zubne proteze
EP3051634A4 (en) Connector
DK2976101T3 (da) Behandlingsfremgangsmåde
EP2958454A4 (en) MAGNETOTHERAPEUTIC BAND
DK3041506T3 (da) Behandlingsfremgangsmåde
GB201304811D0 (en) Novel treatment for hypertension
FI10329U1 (fi) Kaasujen käsittelylaitteisto
DK2941271T3 (da) C-terminale hsp90-inhibitorer til behandling af hypofyseadenomer
FI20136034A7 (fi) Sauna
ES1078754Y (es) Trampa capturadora de avispas en colmenas
FR3008292B1 (fr) Perloir
EP2958932A4 (en) THERAPEUTICS